[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7436 Introduced in House (IH)]

<DOC>






118th CONGRESS
  2d Session
                                H. R. 7436

  To direct the Comptroller General of the United States to prepare a 
     report on Federal efforts to address antimicrobial resistance.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 23, 2024

 Mr. Griffith introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
  To direct the Comptroller General of the United States to prepare a 
     report on Federal efforts to address antimicrobial resistance.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Antimicrobial Resistance Research 
Assessment Act of 2024''.

SEC. 2. REPORT ON FEDERAL EFFORTS TO ADDRESS ANTIMICROBIAL RESISTANCE.

    (a) In General.--The Comptroller General of the United States 
shall--
            (1) prepare a report on efforts of the Federal Government 
        to address antimicrobial resistance; and
            (2) not later than 1 year after the date of enactment of 
        this Act--
                    (A) finalize such report; and
                    (B) submit such report to the Congress.
    (b) Contents.--The report required by subsection (a) shall--
            (1) address all efforts of the Federal Government regarding 
        antimicrobial resistance, including any such efforts 
        involving--
                    (A) establishing, maintaining, or operating a task 
                force, committee, or interagency program; or
                    (B) developing a plan or report;
            (2) specify the role of each Federal program and resource 
        in such efforts;
            (3) identify any such efforts that are duplicative;
            (4) recommend ways to improve the coordination of such 
        efforts across the Federal Government;
            (5) identify the results achieved thus far through such 
        efforts;
            (6) describe any such efforts related to phage therapy; and
            (7) with respect to research being federally conducted or 
        supported with respect to antimicrobial resistance--
                    (A) quantify of the costs of such research;
                    (B) if any such research is identified as 
                duplicative pursuant to paragraph (3), recommend 
                approaches for coordinating or consolidating such 
                research to avoid duplication; and
                    (C) recommend whether there should be a central 
                Federal agency to oversee such research.
                                 <all>